Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,62 USD | -7,11% | -5,68% | -46,00% |
15/04 | NEVRO CORP. : RBC Capital Markets is Neutraal over het aandeel | ZM |
11/04 | NEVRO CORP. : Mizuho Securities is Neutraal gestemd over aandeel | ZM |
Vakgebied
Aantal werknemers: 1 215
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medical Devices
100,0
%
| 406 | 100,0 % | 425 | 100,0 % | +4,63% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
86,2
%
| 348 | 85,7 % | 367 | 86,2 % | +5,28% |
International
13,8
%
| 58 | 14,3 % | 59 | 13,8 % | +0,72% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 24-04-23 |
D. Grossman
CHM | Chairman | 63 | 19-03-19 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 15-06-20 |
David Caraway
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-04-14 |
Chief Tech/Sci/R&D Officer | 73 | 20-01-20 | |
Chief Tech/Sci/R&D Officer | 54 | 01-07-16 | |
Geeta Kaveti
CMP | Compliance Officer | - | - |
Kerry Bradley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael DeMane
BRD | Director/Board Member | 67 | 17-03-11 |
Angeline McCabe
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 17-03-11 |
Karen Prange
BRD | Director/Board Member | 60 | 17-12-19 |
D. Grossman
CHM | Chairman | 63 | 19-03-19 |
Director/Board Member | 64 | 19-03-19 | |
Kevin O'Boyle
BRD | Director/Board Member | 68 | 19-03-19 |
Frank Fischer
BRD | Director/Board Member | 82 | 01-10-12 |
Susan Siegel
BRD | Director/Board Member | 63 | 02-12-20 |
Shawn McCormick
BRD | Director/Board Member | 59 | 01-09-14 |
Sridhar Kosaraju
BRD | Director/Board Member | 46 | 31-08-21 |
Kevin Thornal
CEO | Chief Executive Officer | 50 | 24-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 37 364 308 | 35 473 980 ( 94,94 %) | 682 916 ( 1,828 %) | 94,94 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,00% | 459 mln. | |
-2,92% | 185 mld. | |
-3,80% | 107 mld. | |
-5,48% | 67,55 mld. | |
+11,22% | 54,6 mld. | |
+16,74% | 47,42 mld. | |
+2,38% | 42,24 mld. | |
+4,56% | 28,24 mld. | |
+1,64% | 26,42 mld. | |
+11,34% | 25,66 mld. |
- Beurs
- Aandelen
- Koers NVRO
- Onderneming Nevro Corp.